Madrigal Pharmaceuticals Inc
MDGL - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.67B
Close$
$1107.92
176.7% upside
Current Fair Value
176.7% upsideUndervalued by 176.7% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $11.67 Billion |
|---|---|
| Enterprise Value | $11.73 Billion |
| Earnings per Share | $-12.85 |
| Beta | -1.05 |
| Outstanding Shares | 29,145,271 |
Return
| Return on Equity | -62.07% |
|---|---|
| Return on Assets | -26.12% |
| Return on Invested Capital | -39.96% |
Valuation & Multiples
| P/E Ratio | -33.39 |
|---|---|
| PEG | -90.15 |
| Price to Sales | 9.1 |
| Price to Book Ratio | 23.55 |
| Enterprise Value to Revenue | 9.13 |
| Enterprise Value to EBIT | -33.71 |
| Enterprise Value to Net Income | -37 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.66 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 3, 2026
EPS Estimate
$-0.86
Consensus analyst estimateRevenue Estimate
$404.17 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 18, 2027
EPS Estimate
$-0.57
Consensus analyst estimateRevenue Estimate
$475.30 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 63.36% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.91%▼ 80.66% |
|---|---|
| Total Invested | $132.82M▼ 98.96% |
| Investors Holding | 112▼ 327.00% |
About Madrigal Pharmaceuticals Inc
CEO: Rebecca Taub
